Abstract

    Open Access Case Report Article ID: AHCRR-4-115

    Recurrent thrombosis in a multiple myeloma patient with low risk for thrombosis despite being on thromboprophylaxis

    Chow Siew Kian* and Fu Mei Sian

    It is a well-known fact that multiple myeloma (MM) patients have an increased risk for thromboembolic events involving both the venous and arterial territories. The etiologies can be multifactorial, for example, activation of procoagulant factors, acquired protein C resistance, MM-specified and treatment-related factors. The risk of venous thrombosis is high when patients receive treatment with thalidomide or lenalidomide in combination with dexamethasone or multi-agent chemotherapy. Arterial thromboses occur less compared to venous thrombotic events. Nonetheless, thromboprophylaxis is important in preventing both types of thromboses. In this case study, we reveal a patient whom thrombosis occurred concurrently in both arterial and venous despite being on aspirin prophylaxis.

    Keywords:

    Published on: Feb 19, 2019 Pages: 3-5

    Full Text PDF Full Text HTML DOI: 10.17352/ahcrr.000015
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on AHCRR